Literature DB >> 25438809

Isolated CNS Hodgkin's lymphoma: implications for tissue diagnosis.

Derek L Martinez1, Meena Gujrati, Francois Geoffroy, Andrew J Tsung.   

Abstract

CNS involvement in the setting of lymphoid neoplasia is a clinical situation that requires specific diagnosis due to the disparate treatment regimens recommended for neoplasms of specific lymphoid cell types. Cerebrospinal fluid (CSF) sampling may provide sufficient information to determine the presence of abnormal lymphoid cells but may not be able to further specify the malignant cellular population. In cases where abnormal clinical or radiographic features are present, accurate tissue diagnosis is essential. In this report, we define a rare case of primary CNS intramedullary Hodgkin's lymphoma without leptomeningeal dissemination diagnosed via resectional biopsy of a conus medullaris lesion. The patient received post-resection radiation therapy and subsequently demonstrated radiographic and clinical improvement. Lymphoid neoplasia within the CNS comprises a diverse group with varying response and survival rates. Treatment hinges upon accurate diagnosis as chemotherapy varies widely among Hodgkin's and non-Hodgkin's lymphoma. While CSF sampling may yield a positive result with sufficiency to diagnose an abnormal lymphoid cell population, tissue is necessary for further defining cellular pathology. In this report, we define a rare case of primary CNS intramedullary Hodgkin's lymphoma without leptomeningeal dissemination via resectional biopsy of a conus medullaris lesion. In cases where abnormal enhancement is found in eloquent CNS regions and lymphoid neoplasia is suspected, management often entails either stereotactic biopsy or CSF sampling. While CSF analysis may differentiate malignancy at a low rate, tissue diagnosis via paraffin block immunohistochemistry is necessary to further classify malignancy as primary or peripheral, Hodgkin's or non-Hodgkin's lymphoma, or other such as metastatic leptomeningeal dissemination and glioma. Within the subtypes of lymphoid neoplasms, treatment regimens vastly differ and thus accurate tissue diagnosis is paramount. We therefore present a rare case of primary CNS intramedullary Hodgkin's lymphoma without leptomeningeal disease in the setting of immunocompromise diagnosed via open resectional biopsy of the conus medullaris.

Entities:  

Keywords:  Reed–Sternberg cells; absent leptomeningeal dissemination; cerebrospinal fluid sampling; open biopsy; primary intramedullary Hodgkin's lymphoma; radiation therapy

Mesh:

Year:  2014        PMID: 25438809      PMCID: PMC6113894          DOI: 10.2217/cns.14.45

Source DB:  PubMed          Journal:  CNS Oncol        ISSN: 2045-0907


  11 in total

1.  Primary intramedullary spinal cord lymphoma.

Authors:  E P Flanagan; B P O'Neill; A B Porter; G Lanzino; T M Haberman; B M Keegan
Journal:  Neurology       Date:  2011-08-10       Impact factor: 9.910

2.  Intramedullary spinal cord metastasis in Hodgkin's disease. Rapid diagnosis and treatment resulting in neurologic recovery.

Authors:  J M Lyding; A Tseng; A Newman; S Collins; W Shea
Journal:  Cancer       Date:  1987-10-15       Impact factor: 6.860

3.  Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte.

Authors:  Bertrand Coiffier; Catherine Thieblemont; Eric Van Den Neste; Gérard Lepeu; Isabelle Plantier; Sylvie Castaigne; Sophie Lefort; Gérald Marit; Margaret Macro; Catherine Sebban; Karim Belhadj; Dominique Bordessoule; Christophe Fermé; Hervé Tilly
Journal:  Blood       Date:  2010-06-14       Impact factor: 22.113

4.  Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.

Authors:  David B Duggan; Gina R Petroni; Jeffrey L Johnson; John H Glick; Richard I Fisher; Joseph M Connors; George P Canellos; Bruce A Peterson
Journal:  J Clin Oncol       Date:  2003-02-15       Impact factor: 44.544

5.  High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices.

Authors:  S J Horning; N J Chao; R S Negrin; R T Hoppe; G D Long; W W Hu; R M Wong; B W Brown; K G Blume
Journal:  Blood       Date:  1997-02-01       Impact factor: 22.113

6.  CNS Hodgkin lymphoma.

Authors:  Elizabeth R Gerstner; Lauren E Abrey; David Schiff; Andrés J M Ferreri; Andrew Lister; Silvia Montoto; Richard Tsang; Eckhard Thiel; Francesc Graus; Dirk Behringer; Gerald Illerhaus; Susan Weaver; Patrick Wen; Alfredo Voloschin; Nancy Lee Harris; Tracy T Batchelor
Journal:  Blood       Date:  2008-06-30       Impact factor: 22.113

7.  Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07.

Authors:  Tracy Batchelor; Kathryn Carson; Alison O'Neill; Stuart A Grossman; Jane Alavi; Pamela New; Fred Hochberg; Regina Priet
Journal:  J Clin Oncol       Date:  2003-03-15       Impact factor: 44.544

8.  Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496).

Authors:  Leo I Gordon; Fangxin Hong; Richard I Fisher; Nancy L Bartlett; Joseph M Connors; Randy D Gascoyne; Henry Wagner; Patrick J Stiff; Bruce D Cheson; Mary Gospodarowicz; Ranjana Advani; Brad S Kahl; Jonathan W Friedberg; Kristie A Blum; Thomas M Habermann; Joseph M Tuscano; Richard T Hoppe; Sandra J Horning
Journal:  J Clin Oncol       Date:  2012-11-26       Impact factor: 44.544

9.  Hodgkin's Lymphoma: A Review of Neurologic Complications.

Authors:  Sean Grimm; Marc Chamberlain
Journal:  Adv Hematol       Date:  2010-10-11

10.  Detection of cancer cells in the cerebrospinal fluid: current methods and future directions.

Authors:  Cody L Weston; Michael J Glantz; James R Connor
Journal:  Fluids Barriers CNS       Date:  2011-03-03
View more
  4 in total

1.  Intracerebral manifestation of iatrogenic, immunodeficiency-associated polymorphic B-LPD with morphology mimicking Hodgkin lymphoma: a case report and literature review.

Authors:  Leonie Saft; Marina Perdiki-Grigoriadi; Georgios Rassidakis
Journal:  J Hematop       Date:  2022-03-04       Impact factor: 0.625

Review 2.  Rare central nervous system lymphomas.

Authors:  Furqaan Ahmed Kaji; Nicolás Martinez-Calle; Vishakha Sovani; Christopher Paul Fox
Journal:  Br J Haematol       Date:  2022-03-16       Impact factor: 8.615

Review 3.  Extranodal classical Hodgkin lymphoma involving the spinal cord: case report and review of the literature.

Authors:  Katell Le Dû; Nicolas Alarion; Hassan Rabi; Olivier Casasnovas; Philippine Robert; Amandine Durand; Bénédicte Burlet; Claire Tabouret-Viaud; Selim Ramla; Laurent Martin; Cédric Rossi
Journal:  CNS Oncol       Date:  2022-06-13

4.  Primary intradural Hodgkin lymphoma of the conus medullaris and cauda equina: case report.

Authors:  Timothy J Williamson; Michael Wang; Jonathan Clark; Julia Williams; Armin Drnda
Journal:  CNS Oncol       Date:  2020-09-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.